Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 85
Filtrar
1.
Clin Exp Dermatol ; 46(6): 1075-1078, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33577095

RESUMEN

During the SARS-CoV-2 (COVID-19) pandemic, an unusual outbreak of yellow-brown pigmentation on the skin of children was reported. Because of the restrictions on movement promulgated during the lockdown, most consultancies were performed using teledermatology. Data concerning personal care products and application of topical substances were collected, which revealed use of the same brand of wipes for all patients. A liquid chromatography-mass spectrometry analysis was performed to compare the components of the wipes before and after the observation of the pigmentation, in order to detect the responsible substance. This analysis revealed a level about 10-fold higher than normal of ascorbic acid and its oxidation products (dehydroascorbic acid and L-threonic acid) in the wipes associated with the pigmentation. These 'colouring wipes' represent a peculiar but harmless phenomenon that highlights the importance of careful questioning about personal care products used by patients.


Asunto(s)
Ácido Ascórbico/efectos adversos , COVID-19/epidemiología , Pandemias , Cuarentena , Pigmentación de la Piel/efectos de los fármacos , Piel/patología , Preescolar , Femenino , Humanos , Lactante , Masculino , Espectrometría de Masas , Vitaminas/efectos adversos
3.
J Eur Acad Dermatol Venereol ; 27(3): e276-81, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22759244

RESUMEN

BACKGROUND: Alopecia areata (AA) is an autoimmune disease affecting about 2% of the population, which has a considerable impact on quality of life (QoL). There are no disease-specific questionnaires to assess QoL in patients suffering from AA. OBJECTIVE: To validate a new disease-specific questionnaire for AA, named AA-QLI, and to compare the consequent Quality of Life Index (QLI) with the commonly known Dermatology Life Quality Index (DLQI) to verify if it can provide a more comprehensive tool for patients. METHODS: A total of 50 patients affected by AA were administered both the AA-QLI, created by us, and the well-known DLQI. With the aim to detect suitable QLI, we propose to use two multivariate analyses: • a principal component analysis approach on the data collected with both questionnaires to compare their capability to measure the QoL; • a structural equation modelling on our AA-QLI to identify which category of symptoms mostly affects the QoL. RESULTS: The scores of both the questionnaires are quite close, except for a few cases. Statistical analysis shows a higher specificity of the AA-QLI for evaluating QoL. Among the three areas in which AA-QLI is divided, 'Relationship' has a major impact on the QLI, followed by 'Subjective symptoms'; 'Objective signs' has a lower weight on the QLI. CONCLUSION: AA-QLI is a good instrument to evaluate the real impact of AA on QoL. It can be helpful both for the physician and for the patient.


Asunto(s)
Alopecia Areata/fisiopatología , Calidad de Vida , Adolescente , Adulto , Anciano , Humanos , Persona de Mediana Edad , Análisis Multivariante , Encuestas y Cuestionarios , Adulto Joven
4.
Eur J Gynaecol Oncol ; 34(5): 415-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24475574

RESUMEN

INTRODUCTION: Minimally invasive surgery to stage early ovarian cancer is still regarded as pioneering among gynecologic oncologists. Previous retrospective experiences demonstrated the safety and feasibility of laparoscopy in this field. AIMS: To review the laparoscopic staging procedure in a series of patients with early ovarian cancer and compare results with the literature. MATERIALS AND METHODS: From January 2004 to September 2011, 19 patients with apparent early stage ovarian/fallopian tube cancer Stage IA to IC underwent either primary treatment or completion staging by laparoscopy. Surgical, pathologic, and oncologic outcomes were analyzed. RESULTS: The mean operative time was 212 +/- 69 minutes. Three patients (16%) underwent fertility sparing surgery. The mean estimated blood loss was two +/- two g/dl. The mean number of pelvic and para-aortic lymph nodes collected was 17 (range 7-27) and 14 (range 8-21), respectively. The mean volume of ovarian/tubal tumor was 119 cm3 (range 1.5-500). The disease was reclassified to a higher stage in ten women (52%). One major intraoperative complication (five percent) occurred which required the conversion to laparotomy. The mean follow up period was 30 +/- 16 months (range 10-74). Overall survival and disease-free survival were 100% and 84%, respectively. CONCLUSIONS: Laparoscopic staging of early ovarian cancer appears to be feasible and comprehensive when performed by gynecologic oncologists experienced with advanced laparoscopy.


Asunto(s)
Laparoscopía/métodos , Neoplasias Ováricas/cirugía , Adulto , Anciano , Femenino , Humanos , Laparoscopía/efectos adversos , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Ováricas/mortalidad , Neoplasias Ováricas/patología , Estudios Retrospectivos
6.
Mycoses ; 54(1): 87-8, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19638002

RESUMEN

We report on an adult patient with tinea capitis caused by Microsporum canis, who presented with diffuse alopecia and follicular pustules, mimicking folliculitis decalvans. Examination of the scalp showed severe alopecia with prominent involvement of the frontal and vertex scalp: the skin was markedly erythematous with pustules and brownish crusts. Videodermoscopy revealed visible follicular ostia, numerous pustular lesions and several comma hairs. Fluconazole 150 mg a week for 8 weeks associated with ketoconazole shampoo cleared the inflammatory lesions and produced complete hair regrowth.


Asunto(s)
Foliculitis/diagnóstico , Microsporum/aislamiento & purificación , Tiña del Cuero Cabelludo/diagnóstico , Antifúngicos/administración & dosificación , Femenino , Fluconazol/administración & dosificación , Foliculitis/tratamiento farmacológico , Foliculitis/microbiología , Foliculitis/patología , Humanos , Microsporum/fisiología , Persona de Mediana Edad , Cuero Cabelludo/microbiología , Cuero Cabelludo/patología , Tiña del Cuero Cabelludo/tratamiento farmacológico , Tiña del Cuero Cabelludo/microbiología , Tiña del Cuero Cabelludo/patología
7.
J Clin Neurosci ; 91: 20-22, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34373027

RESUMEN

Cancer-related coagulopathy is a known cause of stroke and can lead to formation of thrombi with a unique composition. The effectiveness of mechanical thrombectomy in cancer patients is still unknown. The aim of the study was to evaluate the rate of successful reperfusion and the clinical outcome in cancer patients with stroke treated with endovascular therapies, compared to patients without cancer. We performed a retrospective analysis of consecutive patients with ischemic stroke treated with endovascular therapies at our hospital between January 2008 and January 2016. A sub-group analysis was performed including only patients with cryptogenic stroke. We included in the final analysis 14 patients with active cancer and 267 patients without cancer. Successful reperfusion was achieved in 79% of patients without cancer, and 71% of patients with active cancer (P = 0.68). Patients with cryptogenic stroke and active cancer had a lower reperfusion rate compared to patients with cryptogenic stroke without active cancer, although not significantly so (2/4 cancer patients, 50% vs 37/50, 74%, p: 0.31). Mortality rate was higher among cancer patients. Hemorrhagic transformation occurred in similar proportions in the two groups. Endovascular treatment in cancer patients seems, thus, effective.


Asunto(s)
Isquemia Encefálica , Procedimientos Endovasculares , Accidente Cerebrovascular Isquémico , Neoplasias , Accidente Cerebrovascular , Isquemia Encefálica/complicaciones , Isquemia Encefálica/cirugía , Humanos , Neoplasias/complicaciones , Neoplasias/cirugía , Estudios Retrospectivos , Accidente Cerebrovascular/complicaciones , Accidente Cerebrovascular/cirugía , Trombectomía , Resultado del Tratamiento
11.
Leukemia ; 6(12): 1257-62, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1453771

RESUMEN

In the present study fresh leukemic cells obtained from 23 patients with acute myeloid leukemia (AML; FAB subtypes: three M1, five M2, two M3, five M4, eight M5) were investigated for the membrane expression of the CD4 molecule by cytofluorimetric analysis with an anti-CD4 monoclonal antibody (mAb). In 15 cases the presence of the CD4 mRNA was also investigated using Northern blot analysis. Membrane expression of the CD4 molecule was demonstrated in 19 out of 23 cases, and it was found to be weaker than in CD4+ lymphocytes and monocytes obtained from normal controls. Full-length CD4 mRNA was detected in 12 out of 15 (80%) cases, and AML cells positive for CD4 mRNA expression also expressed the CD4 antigen. Since the CD4 molecule expressed by T cells is associated with p56lck, a member of the src family of intracellular tyrosine kinases, we investigated whether the CD4 molecule expressed by myeloid blasts is also associated with a tyrosine kinase activity. In vitro kinase assays performed on anti-CD4 immunoprecipitates from lysates of myeloid leukemia cells from four CD4+ cases were negative for the presence of a tyrosine kinase activity. This finding was not due to the lack of expression of members of the src family since we were able to detect at least p60src and p59fyn in myeloid leukemia cells. According to our results, the CD4 molecule seems to belong to the phenotypic repertoire of most AML, irrespective of their FAB subtypes. However, in myeloid blasts this molecule is not associated with a tyrosine kinase activity as it occurs in T lymphocytes.


Asunto(s)
Antígenos CD4/análisis , Leucemia Mieloide/inmunología , Proteínas Tirosina Quinasas/análisis , ARN Mensajero/análisis , ARN Neoplásico/análisis , Northern Blotting , Humanos , Inmunofenotipificación , Leucemia Mieloide/clasificación , Leucemia Mieloide/enzimología
12.
Leukemia ; 7(3): 418-25, 1993 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8445947

RESUMEN

In the present study, we have investigated the leukemic cells obtained from 16 patients with acute myeloid leukemia (AML) at diagnosis for the membrane expression of p55 (alpha) and p75 (beta) interleukin-2 receptor (IL-2R) chains using specific monoclonal antibodies (mAbs), as well as for the presence of their transcripts using Northern blot analysis. In addition, immunoprecipitation of the p75 membrane molecule with TU27 and Mik-beta 1 mAbs was carried out in selected cases. The p75 IL-2R beta transcripts were detected in all cases, whereas the membrane p75 molecule was demonstrable by flow cytometry in three cases. However, data from the immunoprecipitation analysis suggest that the lack of the p75 IL-2R detection by flow cytometry might be caused by the low density of molecules per cell rather than the fact that the specific mRNA is not translated into the p75 surface molecule. In addition, a consistent membrane positivity with an anti-p55/CD25 mAb, present on fresh uncultured blasts in 37.5% of the cases, became detectable after short-term culture in 75% of cases. In each individual case, a strict correlation was found between membrane CD25 reactivity and the expression of p55 mRNA. Taken together, our data suggest that the expression of both alpha (p55) and beta (p75) IL-2R molecules is a common feature of leukemic cells in AML, and provide new arguments for reassessing the possible role of IL-2 in leukemic growth.


Asunto(s)
Leucemia Mieloide/patología , Receptores de Interleucina-2/análisis , Enfermedad Aguda , Anticuerpos Monoclonales , Especificidad de Anticuerpos , Northern Blotting , Humanos , Leucemia Monocítica Aguda/genética , Leucemia Monocítica Aguda/patología , Leucemia Monocítica Aguda/fisiopatología , Leucemia Mieloide/genética , Leucemia Mieloide/fisiopatología , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/patología , Leucemia Mieloide Aguda/fisiopatología , Leucemia Mielomonocítica Aguda/genética , Leucemia Mielomonocítica Aguda/patología , Leucemia Mielomonocítica Aguda/fisiopatología , Leucemia Promielocítica Aguda/genética , Leucemia Promielocítica Aguda/patología , Leucemia Promielocítica Aguda/fisiopatología , Sustancias Macromoleculares , Proteínas de la Membrana/genética , Proteínas de Neoplasias/genética , Pruebas de Precipitina , ARN Mensajero/genética , Receptores de Interleucina-2/genética , Receptores de Interleucina-2/fisiología , Transcripción Genética/genética
13.
Leukemia ; 8(4): 672-6, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8152264

RESUMEN

In the present study, we explored the suitability of a new cell fixative (ORTHO PermeaFix, OPF) for the detection by flow cytometry of intracellular molecules while preserving the cell surface immunoreactivity, scatter features and morphology. The effect of OPF was investigated on whole blood of ten normal donors, and on separated blasts of 17 leukemic patients. OPF fixation for 45 min to 24 h maintained the morphology of lymphoid cells with minimal cellular distortion and scatter changes, and only slightly modified cell surface immunoreactivity. For at least 1 week following fixation, the cells were still suitable for immunostaining with monoclonal antibodies that recognize the main lymphoid populations. These included CD3, CD4 and CD8 for T-cell subsets, CD19 and CD16 for B lymphocytes and NK cells, and CD45 for leukocyte common antigen (LCA). The OPF fixation of leukemic cells allowed the simultaneous detection of nuclear TdT in conjunction with membrane CD19, and with membrane and/or cytoplasmic CD22 in common-ALL, as well as with cytoplasmic CD3 in T-ALL cases. Our findings suggest that with the introduction of this new fixative into the routine laboratory service, a number of convenient and practical arrangements can be made which increase the efficiency of immunodiagnosis. Small laboratories with no inhouse flow-cytometric facilities can now accumulate OPF-treated whole blood samples for at least 3-4 days and send these to reference laboratories. In addition, the immunodiagnosis of acute leukemia is greatly facilitated by combination staining for membrane and intracellular antigens both at diagnosis and when the analysis of minority populations is warranted for detecting minimal disease.


Asunto(s)
Antígenos de Superficie/análisis , Fijadores/farmacología , Leucemia-Linfoma Linfoblástico de Células Precursoras/inmunología , Antígenos CD/análisis , Antígenos de Neoplasias/análisis , Núcleo Celular/inmunología , Citoplasma/inmunología , Citometría de Flujo , Humanos
14.
Leukemia ; 7(10): 1552-6, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8412317

RESUMEN

Purified leukemic cells from 30 acute myeloid leukemia (AML) cases at diagnosis were investigated for the presence of interleukin 8 (IL-8) mRNA by Northern blot analysis. IL-8 specific transcripts were detected in uncultured blasts in 14/30 cases, 10/14 from patients with M4-M5 and 4/14 from cases with M0-M3 morphology. The transcript expression was associated with the detection of IL-8 molecule in blast cells by immunostaining performed on cytospin preparations. After 24-hour culture, a strong up-regulation or the appearance in cases negative before culture of IL-8 mRNA was observed in all cases tested, and culture supernatants contained high amounts of IL-8. Our data demonstrate that leukemic cells in AML are equipped with the functional apparatus for IL-8 production. Since IL-8 displays a wide range of biological activities, including the regulation of some membrane molecules relevant to adhesion and migration processes, its production by AML blasts might be of relevance for the pattern of leukemic growth.


Asunto(s)
Expresión Génica/genética , Interleucina-8/biosíntesis , Interleucina-8/genética , Leucemia Mieloide/genética , Leucemia Mieloide/metabolismo , ARN Mensajero/genética , Enfermedad Aguda , División Celular/fisiología , Humanos , Leucemia Monocítica Aguda/genética , Leucemia Monocítica Aguda/metabolismo , Leucemia Monocítica Aguda/patología , Leucemia Mieloide/patología , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/metabolismo , Leucemia Mieloide Aguda/patología , Leucemia Mielomonocítica Aguda/genética , Leucemia Mielomonocítica Aguda/metabolismo , Leucemia Mielomonocítica Aguda/patología , Leucemia Promielocítica Aguda/genética , Leucemia Promielocítica Aguda/metabolismo , Leucemia Promielocítica Aguda/patología , Células Tumorales Cultivadas
17.
Arch Dermatol ; 137(5): 641-6, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11346342

RESUMEN

BACKGROUND: The degree of androgenetic alopecia is generally evaluated either by global clinical scales or time-consuming methods like phototrichogram or histological studies. We describe a new clinical and reliable scoring method based on hair diameter diversity. OBSERVATIONS: (1) The clinical macroscopic scoring we propose for hair density was significantly correlated with Hamilton classification and with histological hair density. (2) Diversity in hair diameter was the main and most accurate clinical parameter linked to follicle miniaturization. (C) The anagen-telogen ratio decreased in parallel with the decrease in clinical hair density score. CONCLUSIONS: Considering that hair follicle miniaturization is the key point during androgenic alopecia onset and development, diversity in hair diameter represents an important feature to consider as an accurate clinical sign reflecting hair follicle miniaturization. Moreover, diversity in hair diameter seems to be an easily accessible and reliable parameter that should be taken into consideration for further characterization of hair disorders. By itself, we believe that this clinical feature constitutes a new tool of substantial help for the diagnosis and management of androgenic alopecia.


Asunto(s)
Alopecia/patología , Cabello/patología , Adulto , Alopecia/etiología , Andrógenos/fisiología , Biopsia , Folículo Piloso/patología , Humanos , Masculino , Persona de Mediana Edad
18.
Int J Pharm ; 190(1): 73-81, 1999 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-10528099

RESUMEN

The effects of process conditions on the granulometric characteristics of a placebo formulation prepared in a 10 l high shear mixer by single-step melt granulation were studied. The factors under investigation were: binder grade, mixer load, presence of the deflector (all of analysed at two levels), binder concentration, impeller speed, massing time, type of impeller blades (these four at three levels) and jacket temperature (considered at four levels). Two granule characteristics were analysed: the geometric mean diameter and the percentage of particles finer than 315 microm. In order to screen simultaneously the above-mentioned factor levels, an asymmetrical factorial design was adopted, which allowed the reduction in the number of runs from 2592 to 25. Additionally, this technique permitted the selection of the factor levels which have the major 'weight' on the two granule characteristics under study. Two additional trials were performed to attest the screening validity.


Asunto(s)
Química Farmacéutica/métodos , Proyectos de Investigación , Química Farmacéutica/instrumentación , Composición de Medicamentos , Derivados de la Hipromelosa , Lactosa/química , Metilcelulosa/análogos & derivados , Metilcelulosa/química , Microscopía Electrónica de Rastreo , Análisis Multivariante , Tamaño de la Partícula , Polietilenglicoles/química , Polvos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA